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Background: An increase in chronic conditions is currently the greatest threat to human health and to the
sustainability of health systems. Risk adjustment systems may enable population stratification programmes to be
developed and become instrumental in implementing new models of care.
The objectives of this study are to evaluate the capability of ACG-PM, DCG-HCC and CRG-based models to predict
healthcare costs and identify patients that will be high consumers and to analyse changes to predictive capacity
when socio-economic variables are added.
Methods: This cross-sectional study used data of all Basque Country citizens over 14 years of age (n = 1,964,337)
collected in a period of 2 years. Data from the first 12 months (age, sex, area deprivation index, diagnoses,
procedures, prescriptions and previous cost) were used to construct the explanatory variables. The ability of models
to predict healthcare costs in the following 12 months was assessed using the coefficient of determination and to
identify the patients with highest costs by means of receiver operating characteristic (ROC) curve analysis.
Results: The coefficients of determination ranged from 0.18 to 0.21 for diagnosis-based models, 0.17-0.18 for
prescription-based and 0.21-0.24 for the combination of both. The observed area under the ROC curve was
0.78-0.86 (identifying patients with a cost higher than P-95) and 0.83-0.90 (P-99). The values of the DCG-HCC models
are slightly higher and those of the CRG models are lower, although prescription information could not be used in
the latter. On adding previous cost data, differences between the three systems decrease appreciably. Inclusion of
the deprivation index led to only marginal improvements in explanatory power.
Conclusion: The case-mix systems developed in the USA can be useful in a publicly financed healthcare system
with universal coverage to identify people at risk of high health resource consumption and whose situation is
potentially preventable through proactive interventions.
Keywords: Risk-adjustment, Burden of illness, Actuarial prediction, Health risk stratificationBackground
Increased life expectancy combined with other factors
has produced a progressive increase in the prevalence of
chronic diseases and multimorbidity situations, espe-
cially in the older population strata. However, current
healthcare systems were designed to serve primarily
acute episodes of illness and have trouble meeting the
complex healthcare needs that this group of people
present [1]. In addition, a small number of patients with* Correspondence: jon.orueta@osakidetza.net
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reproduction in any medium, provided the ormultiple pathologies requires such a high number of re-
current hospitalisations and other costly treatments that
the cost of their care accounts for the majority of the
budgets of health organisations.
In this context, in 2010 the Basque Government’s De-
partment of Health published a Strategy to tackle the
challenge of Chronicity in the Basque Country [2],
containing a series of policies and projects to reinvent
the healthcare delivery model and adapt it to this new
situation. In order for interventions to be effective and
efficient, they should be implemented among those pa-
tients whose care needs match the profile for which they
were designed. This fact raises the need to develop aLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ment mechanisms.
The risk adjustment models use information obtained
from patients to explain the variation in healthcare re-
source consumption, cost and the outcomes of the care
they receive. To do this, models were developed using
different explanatory variables such as demographics,
past consumption of health resources and health status
[3-7]. Incorporating clinical variables generates greater
explanatory power. Moreover, systems that contain these
variables are easier to interpret for the healthcare profes-
sionals responsible for caring for these patients.
Among the best-known predictive instruments are Ad-
justed Clinical Groups (ACG-PM) [8], Diagnostic Cost
Groups/Hierarchical Condition Categories (DCG-HCC)
[9] and Clinical Risk Groups (CRG) [10]. All three were
designed in the U.S., and are robust systems from a stat-
istical point of view and versatile in their applications.
Their usefulness has been proven in public and private
health organisations over a number of years. They are
able to explain a large portion of the variability in a pop-
ulation’s use of health services and to provide a forecast
estimate of the volume of healthcare resources that each
individual will require the following year. The most re-
cent versions combine information about diagnoses, pre-
scriptions, previous cost and use of certain procedures.
Despite their undeniable appeal, these instruments
also have some limitations resulting from their failure to
include other factors that influence health, such as life-
style, socio-economic variables and other factors relating
to the social environment [11,12].
There may also be doubts about the validity and
applicability of these instruments in our setting. Al-
though several studies have demonstrated the ability of
diagnosis-based case-mixes to retrospectively explain
the use of health resources in Spain [13,14] and other
countries, there are few references comparing different
predictive tools in a national system similar to ours. In
addition, the limited development of health databases
for administrative purposes in Spain may pose obsta-
cles to the implementation of risk prediction models.
This paper has two objectives. First, to verify the valid-
ity of ACG-PM, DCG-HCC and CRG systems in terms
of predicting healthcare costs and identifying in advance
those patients that will consume a high level of re-
sources the following year; and second, to analyse the
potential improvement in the predictive capacity of these
instruments when variables related to patients’ socio-
economic status are incorporated.
Methods
This is a cross-sectional study carried out within the health
system of the Basque Country (Spain). The Spanish
National Health System (SNS) provides universal coverage.This coverage and the benefits package are common to
Spanish citizens and foreign nationals within Spanish
national territory.
The SNS is publicly funded through general taxes. At
the point of delivery, provision is free of charge, with the
exception of pharmaceuticals prescribed, which entail a
co-payment.
The regional organizational structure is the result of a
devolution process. Geopolitically, Spain is made up of
17 regions referred to as Autonomous Communities.
The 17 regional health ministries have primary control
over the funding, organization, and delivery of health
services within their territory. These competencies were
transferred over the past 30 years and, in particular, the
Basque Health Service, called Osakidetza, was created
in 1983.
In the Basque Country, there is a purchaser provider
split, with the Department of Health and Consumer
Affairs of the Basque Government being responsible for
policy making, for public health and for planning and
financing health care. Osakidetza is the only public
provider of health services in the region, including pri-
mary care, hospital care (both acute and long-term
care), specialist outpatient clinics, emergencies, and
mental health. All health professionals in Osakidetza
are salaried.
Primary Care is structured in Primary Care Areas, in
which primary care is provided through one or more
Health Centers under criteria designed to achieve a bal-
ance between optimum accessibility and managerial effi-
ciency. There are a total of 1835 doctors working in
primary care (1544 general practitioners [GPs] and 291
pediatricians); they work in teams and act as gatekeepers
for the other levels of care. Each citizen is on the list of
a given primary care doctor and nurse [15].
The study population was composed of all persons
over 14 years of age, registered in Osakidetza on 1
September 2008. The study period corresponds to two
consecutive 12-month intervals. Data from the first
year (01 September 2007 to 31 August 2008) were used
to develop the explanatory variables and those from the
second year (01 September 2008 to 31 August 2009)
for the response variables. A minimum monitoring
period was established in the first year, including only
those people that were assigned to a doctor in Osakidetza
for at least 6 months, regardless of whether or not they
had any contact with the health services (n =1,973,971).
Of these, 28,182 people did not complete the second
follow-up year due to death (n = 18,548), transfer or
other causes (n = 9,634). Those citizens in the study
population who died during the second year were in-
cluded, whereas those who withdrew for other reasons
were not. As such, the final population consisted of
1,964,337.
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Case-mix systems are used in the USA to classify the
population from claim data. Since this information sys-
tem is not operative in Spain, data were extracted from
the available sources. For this study, we obtained per-
mission from the Basque Health Service to use the
Basque Country population stratification program
(PREST) database. PREST uses an opaque identifier to
ensure patient confidentiality and contains information
from primary care electronic medical records (PC-
EMR), minimum basic data set of hospital discharge
reports (MBDS) and computerised files from day hospi-
tals, emergency departments and specialised outpatient
offices. These data were as follows:
– Demographic data: age, sex and census area of
residence
– ICD-9-CM codes for diagnoses from each contact
with primary care, hospital admissions and day
hospitals. The latter two also contained information
on procedures. The coding is done in hospitals by
clinical documentation specialists, but in primary
care the doctors themselves must perform this task
when establishing or modifying a diagnosis. A more
detailed description of this process can be found
elsewhere [16]. In order to avoid the possible
inclusion of long-term diseases that were not
currently active, we only included the diseases that
were considered reason for encounter, according to
the annotations of the physicians, and involved in
some clinical action, such as cause of prescription,
new clinical notation or derived visit, during the
period of study.
– Prescriptions in primary care, which are coded
automatically in the PC-EMRs according to the
World Health Organization (WHO) Anatomical
Therapeutic Chemical (ATC) system [17].
Regarding the cost, this was obtained directly for pri-
mary care prescriptions recorded in PC-EMR. In the
other cases (visits to emergency departments, outpatient
specialty care and primary care doctors and nurses; lab
tests and X-rays requested in primary care; some proce-
dures such as dialysis, radiation therapy or chemother-
apy performed in day hospitals) the number of services
provided to each patient was multiplied by their stand-
ard cost (the average cost of each service provided to a
patient treated in Osakidetza, according to calculations
made by the aforementioned organisation). The costs of
hospital stays and major outpatient surgical procedures
were calculated according to the weights of their corre-
sponding Diagnosis Related Groups (DRGs). Services for
which no information was available were excluded from
the cost estimate: Mental Health (both admissions andoutpatient visits), hospital-at-home services and day hos-
pitals (except the above-mentioned procedures), out-
patient rehabilitation, medical transport, prostheses and
other equipment delivered to patients at home. It was
estimated that the total cost of excluded services
corresponded to 28.2% of the overall budget.
The deprivation index of the census tract (median
population size = 1,200 inhabitants) of residence pro-
posed by the MEDEA project [18] was used as a proxy
of individual socioeconomic position. Five simple indica-
tors were included in this index (year 2001): Unemploy-
ment, low educational level, low educational level in
young people (16–29 years), manual workers, and tem-
porary workers. The deprivation index was categorised
in quintiles.Classification systems for patients
ACG-PM version 9.0, CRG version 1.6 and DCG-HCC
(models ID#26, ID#69 and ID#71) were used for this
study. A brief description of them can be found as
Additional file 1:
– CRGs [10] is a cell-based model in which each
person is assigned to one mutually exclusive
category, based on clinical criteria; the total number
of CRGs is 1,076. In this study it was not possible to
add information on prescriptions, since the Basque
country organisation uses the WHO ATC system,
which is rejected by the CRG v1.6 software.
– DCG-HCC [9] are a regression-model. All diagnoses
and prescriptions are classified into clinically
homogeneous groups that are employed to predict
the cost of each patient. In this study, 117 categories
for diagnoses and 203 for prescriptions were
included as independent variables.
– ACG-PM [8] adopts a mixed approach. Patients are
categorised in mutually exclusive categories, of
which the model uses 34. Other markers are
incorporated alongside them, with the complete
model comprising 180 variables generated from
diagnoses and 65 from prescriptions.Statistical models
From the information obtained with the use of the three
case-mixes, several regression models were constructed
using the cost of the second year as the outcome vari-
able. To avoid overfitting problems and to confirm that
the results do not depend on the sample, a fivefold cross
validation was carried out. Thus, the sample was split
into five random subsamples and model fitting was
performed five times, considering four of these subsam-
ples as the training set, and the remaining one as the test
set, each time. The statistics employed to evaluate and
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derived from this cross validation.
The coefficient of determination R2 was used to meas-
ure the explanatory power. First, adjustments were made
to models whose independent variables were the out-of-
the-box risk scores offered directly by the case-mix devel-
opers. Then multiple regression models were recalibrated
to our population dataset, in which clinical variables
(groups based on diagnoses or drugs from the case-mix),
previous cost and socio-economic variables (deprivation
index) were successively added to the demographic vari-
ables (age and sex).
OLS (Ordinary Least Squares) statistical models do
not adequately match the analysed data, as none of the
variables follows a normal distribution and addition-
ally, they do not take into account the hierarchical na-
ture of the data (patients grouped in lists of primary
care doctors, those working in health centres and cen-
tres clustered in health districts). Therefore, two-part
models and hierarchical models were also used, includ-
ing the 3 levels of grouping listed above. Because these
models do not directly provide an R2, their results
were compared with those obtained by OLS using
MAPE (Mean Absolute Prediction Error), expressed as
a percentage (dividing the obtained value by the ob-
served average cost).
In order to check the validity of these systems to iden-
tify people that will require high resource consumption
the following year, logistic regression models were de-
veloped in which the dependent variables indicate
whether the person belongs to 5% and 1% of highest-
consuming patients during the second period. The ex-
planatory variables were the same as in the linear
models described above and the area under the ROC
curve was the measure used to evaluate and compare





Age groups N (%) N (%)
14-24 104,686 (5.33%) 99,969 (5.09%) 1.58
25-34 178,767 (9.10%) 171,317 (8.72%) 1.73
35-44 194,187 (9.89%) 187,426 (9.54%) 1.93
45-54 164,620 (8.38%) 165,997 (8.45%) 2.55
55-64 135,889 (6.92%) 138,760 (7.06%) 4.29
65-74 95,032 (4.84%) 107,207 (5.46%) 6.54
75-84 67,272 (3.42%) 95,343 (4.85%) 7.88
85+ 17,091 (0.87%) 40,774 (2.08%) 6.54
Total 957,544 (48.75%) 1,006,793 (51.25%) 3.00Results
Of the study population, 51.2% are women and 21.5%
are aged over 65 years. The distribution of the popula-
tion in age and sex groups, and the averages for unique
prescriptions and diagnoses per patient can be found in
Table 1. More than three quarters of the population had
at least one contact with health services and over 7% re-
quired one or more hospitalisations per year. The overall
average annual consultations per patient ranged between
0.31-0.32 for emergencies, 1.70-1.76 for outpatient spe-
cialty care, 4.29-4.47 for primary care doctors and 1.69-
2.09 for nursing consultations. A table in Additional file 2
the distribution of these averages by age group.
Table 2 shows the results obtained by different linear
regression models in terms of R [2]. While the age and
sex-based models explained 7% of the cost variability,
the out-of-the-box models reached values between
13.5% and 20.8%. Regarding those that were re-
calibrated with our data, the coefficients of determin-
ation ranged from 0.18 to 0.21 for diagnosis-based
models, 0.17-0.18 for prescription-based and 0.21-0.24
for the combination of both. In all cases the values of
the DCG-HCC models are slightly higher and those of
the CRG models lower, although prescription informa-
tion could not be used in the latter. When data on the
cost of the previous year is added, differences between
the three systems decreased appreciably.
Table 3 compares the MAPE of the OLS, two-part and
hierarchical models. The two-part model shows the
worst results and the differences between the OLS and
hierarchical models are small and in both directions.
With regard to the models’ capability to correctly iden-
tify patients located above the 95th and 99th percentiles,
the results are presented in Tables 4 and 5. The out-of-
the-box models for the three case mixes produce differ-


























Table 2 Coefficients of determination (R2) for the case-mix based models to predict the health cost per patient
Demographic variables only ACG-PM CRG DCG-HCC
Out of the box Variables:
A&S + dx + rx + cost percentiles (age < 65) 0,167
A&S + dx + rx + cost percentiles (age 65+) 0,164
A&S + dx 0,135
A&S + dx + cost 0,181
A&S + dx + rx + cost 0,208
Recalibration Variables
Age and Sex (A&S): 0,071
A&S + Only Dx 0,182 0,181 0,213
A&S + Only Rx 0,165 - 0,178
A&S + Dx + Rx 0,211 - 0,236
A&S + Dx + Rx + cost percentile 0,231 0.218* 0,246
A&S + Dx + Rx + cost 0,260 0.254* 0,269
A&S + Dx + Rx + cost + DI 0,260 0.254* 0,269
*The CRG models do not include prescriptions.
Age groups: 14–17; 18–34; 35–44; 45–54; 55–64; 65–69; 70–74; 75–79; 80–84; 85 + .
Cost groups in percentiles: 0–1; 2–10; 11–25; 26–50; 51–75; 76–90; 91–93; 94–95; 96–97; 98 + .
Dx diagnoses, Rx prescriptions, DI Deprivation index.
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to the ACG model for patients over 65; the values from
the ACG model for younger patients are higher than
both of the above, but the highest of all are derived from
the DCG-HCC models. In the case of the recalibrated
models, the AUC values for the DCG-HCC and ACG-
based models display similar behaviour and the AUC
values from CRG models are lower.
The inclusion of the deprivation index resulted in a
marginal improvement in the coefficients of determin-
ation for cost prediction or AUC for identifying patients
with high needs.
Discussion
Our study has revealed that the three case-mix systems
used (ACG-PM, CRG and DCG-HCC) show sufficient
capability to predict use of health resources and identifyTable 3 MAPE (Mean absolute prediction error) expressed as




Age and Sex (A&S) 106.80%
A&S + Only Dx 92.36% 96.36% 91
A&S + Only Rx 93.57% 91
A&S + Dx + Rx 88.41% 87
A&S + Dx + Rx + cost percentile 85.99% 87.70% 85
A&S + Dx + Rx + cost percentile + DI 86.02% 87.70% 85
Dx diagnoses, Rx prescriptions, DI Deprivation index.people with high needs over the next 12 months in an
environment other than that for which they were
designed and using other sources of information,
namely, a publicly-funded universal coverage system and
in the absence of an information system based on the
use of claim data.
While age and sex can predict 7% of the variability in
cost, models that use clinical variables can predict three
times this amount and, when prior costs are added, this
value is even higher, reaching 27%. In this case, the ob-
served increase in the coefficients on addition of the
deprivation index was very small. Moreover, out-of-the-
box models would seem to be a reasonable alternative
for use in situations such as organisations that serve
small populations or that lack sufficient data for self cali-
bration. DCG-based models provided slightly higher ex-
planatory power and the inability to use prescriptionsa percentage of the average cost of different models
s
LS) Two-part Hierarchical models
G-HCC ACG-PM CRG DCG-HCC ACG-PM CRG DCG-HCC
109.09% 106.52%
.26% 114.59% 104.74% 109.74% 95.27% 95.97% 91.52%
.87% 113.84% 115.74% 93.74% 91.98%
.02% 114.96% 114.44% 89.87% 87.26%
.05% 98.52% 96.11% 97.92% 86.97% 87.72% 85.37%
.06% 98.49% 96.09% 97.89% 86.97% 87.72% 85.37%
Table 4 Area under the receiver operating characteristics (ROC) curve of the case-mix based logistic regression models
to identify patients located above the 95th percentile of health spending
Demographic variables only ACG-PM CRG DCG-HCC
Out of the box AUC 95% CI AUC 95% CI AUC 95% CI AUC 95% CI
Variables:
A&S + dx + rx + cost percentiles (age < 65) 0,816 (0.813 - 0.818)
A&S + dx + rx + cost percentiles (age 65+) 0,761 (0.760 - 0.764)
A&S + dx 0,787 (0.786 - 0.789) 0,824 (0.822 - 0.825)
A&S + dx + rx + cost 0,852 (0.851 - 0.853)
Recalibration
Variables:
A&S (Age and sex) 0,774 (0.773 - 0.776)
A&S + Only Dx 0,845 (0.844 - 0.847) 0,797 (0.795 - 0.798) 0,846 (0.845 - 0.848)
A&S + Only Rx 0,833 (0.831 - 0.834) 0,837 (0.836 - 0.838)
A&S + Dx + Rx 0,847 (0.853 - 0.856) 0,858 (0.857 - 0.859)
A&S + Dx + Rx + cost percentile 0,868 (0.866- 0.869) 0.848* (0.847 - 0.849) 0,868 (0.867 - 0.869)
A&S + Dx + Rx + cost percentile + DI 0,868 (0.867 - 0.869) 0.848* (0.847 - 0.850) 0,868
*The CRG models do not include prescriptions.
Age groups: 14–17; 18–34; 35–44; 45–54; 55–64; 65–69; 70–74; 75–79; 80–84; 85 + .
Cost groups in percentiles: 0–1; 2–10; 11–25; 26–50; 51–75; 76–90; 91–93; 94–95; 96–97; 98 + .
Dx diagnoses, Rx Prescriptions, DI Deprivation index.
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comparisons with the latter. In this study, the use of
more complex statistical models than OLS did not pro-
vide any benefits.
As regards the ability of models to correctly detect
people that require large amounts of health resources,
the ACG-PM and DCG-HCC results are relativelyTable 5 Area under the receiver operating characteristics (RO
to identify patients located above the 99th percentile of hea
Demographic variables only
Out of the box AUC 95% CI
Variables:
A&S + dx + rx + cost percentiles (age < 65)
A&S + dx + rx + cost percentiles (age 65+)
A&S + dx
A&S + dx + rx + cost
Recalibration
Variables:
A&S (Age and sex) 0,811 (0.809 - 0.814)
A&S + Only Dx
A&S + Only Rx
A&S + Dx + Rx
A&S + Dx + Rx + cost percentile
A&S + Dx + Rx + cost percentile + DI
*The CRG models do not include prescriptions.
Age groups: 14–17; 18–34; 35–44; 45–54; 55–64; 65–69; 70–74; 75–79; 80–84; 85 + .
Cost groups in percentiles: 0–1; 2–10; 11–25; 26–50; 51–75; 76–90; 91–93; 94–95; 96
Dx diagnoses, Rx prescriptions, DI Deprivation index.similar and are higher than those from CRG. However,
regarding the out-of-the-box option, the DCG-HCC
models show a better behaviour.
This is the first study to compare three case-mix sys-
tems in an entire geographical area, including some so-
cial variables. Moreover, unlike other studies conducted
in Europe [19,20], it combines patient information fromC) curve of the case-mix based logistic regression models
lth spending
ACG-PM CRG DCG-HCC
AUC 95% CI AUC 95% CI AUC 95% CI
0,852 (0.847 - 0.857)
0,779 (0.774 - 0.783)
0,814 (0.811 - 0.818) 0,858 (0.8556 - 0.861)
0,882 (0.880 - 0.885)
0,882 (0.880 - 0.884) 0,829 (0.826 - 0.832) 0,884 (0.882 - 0.886)
0,862 (0.859 - 0.864) 0,865 (0.863 - 0.868)
0,889 (0.887 - 0.891) 0,892 (0.890 - 0.894)
0,897 (0.895 - 0.899) 0,869* (0.866 - 0.871) 0,899 (0.897 - 0.901)
0,897 (0.895 - 0.899) 0,869* (0.866 - 0.872) 0,899 (0.897 - 0.902)
–97; 98 + .
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specialist outpatient care.
However, some limitations should be noted. First, our
healthcare system has no direct cost-per-patient data;
these had to be calculated from the standard prices of
provided services and in some cases (principally mental
health, rehabilitation, hospital at home and some aspects
of day hospital) they could not be obtained.
Moreover, the information sources used are sufficiently
complete for obtaining information on diagnoses in
hospitalised patients, but not in patients treated in out-
patient specialty care or the hospital emergency depart-
ment. With regard to primary care, as is the case
elsewhere, in the Basque Country there is a degree of
underreporting of diagnoses and prescriptions in EMRs.
Also, diagnoses registered only once were accepted,
which may have meant that some annotation or coding
errors by doctors was overlooked. However, records of
primary care doctors tend to suffer from a lack of sensi-
tivity [21] but not specificity, so we do not consider that
this would have exerted a significant effect. In any case,
although it is known that the quality of diagnosis [22]
and prescription [23] information does influence results,
there is no reason to believe that these issues are im-
portant enough to significantly affect our results, espe-
cially given that a requirement of these adjustment
models is their ability to work with imperfect data in the
real world [3,4]. The use of population adjustment sys-
tems requires the application of administrative databases
and other sources of information containing data col-
lected for other purposes, whose limitations are known
[24,25] and it is assumed that even in major chronic dis-
eases, for a proportion of patients receiving diagnoses in
a year, this information is not repeated in the codes
extracted during the following year [3,26].
Finally, a third limitation refers to the social variable
used (deprivation index) which, given its ecological char-
acter, may underestimate the contribution of individual
socioeconomic characteristics.
Our results agree with those found by other authors
and support the robustness of these case-mix systems
[4,6,27]. They display comparable results despite having
been conducted in countries with different types of
health systems, groups of people with different charac-
teristics to those of the general population or using dif-
ferent scenarios for analysis, such as truncation of costs
above a certain threshold. In our case, no transformation
was performed on data to achieve a better fit. No patient
was excluded for not being a healthcare user and neither
were those who, due to death, did not complete the
second year. Although it is commonly accepted that
regression-based models are more flexible and predict
better than those that are cell-based [4-6], in our case
the classification of the population based on diagnosesby CGR categories shows a similar predictive ability to
the ACG-PM system, which uses a mixed system of cat-
egories and regression.
Beyond the predictive capability of the models, other
considerations must be taken into account when
assessing a case-mix, such as transparency of their clas-
sification methods and their ability to provide useful in-
formation from a clinical and not just financial point of
view. Although some simple methods, such as the
number of conditions or medications [28,29] have been
used as a disease burden measure and, in some cases,
to predict mortality, health care costs, number of visits
or other variables. Nevertheless, models based on these
methods would have limited implementation given that
they do not provide a comprehensive approach to the
actual population’ burden of diseases. Additionally, any
estimation based on such models would be seriously af-
fected by the variability in clinical practice patterns
among clinical practitioners.
All three systems, employed in our study, categorise
the diagnoses into clinically relevant groups (260 ACG-
PM, 547 CRG and 1,013 DCG) which in turn can easily
be collapsed into a smaller number of groups and show
a sufficient degree of granularity. The use of these
groups, instead of all the registered ICD-9-CM codes,
can decrease the influence of the diagnosis coding prac-
tices and also provide a manageable number of groups
to identify patients with a given disease or observe the
distribution of diseases in population subgroups. The
DCG-HCC and ACG-PM systems also include an add-
itional method to identify diseases, based on prescrip-
tions. The records of prescribed medication provide a
list of diseases that are being treated, which in our case
has been particularly useful for obtaining data from pa-
tients who only visit their primary care doctor to get
prescriptions, because their condition is stable or be-
cause their disease is receiving care in outpatient
specialised care facilities. Moreover, the coding of drugs
is carried out automatically, which minimises errors and
prevents manipulation by clinicians.
In contrast to USA [30] or other European countries
[31], in a national health system such as the Basque
Country, where the component organisations provide
healthcare to all the residents in a geographical area
and the competition between them is very limited, the
hazard of perverse patient selection practices is im-
possible. However, risk stratification systems have
other applications, such as identification of patients eli-
gible for case-disease and case-management programs.
These interventions are designed to improve the quality
and efficiency of care, especially those who are at risk of
having high future care needs. In any case, identification
of the latter group will be of little interest, unless within it
those patients can be differentiated whose deterioration
Orueta et al. BMC Health Services Research 2013, 13:269 Page 8 of 9
http://www.biomedcentral.com/1472-6963/13/269can be avoided or mitigated by proactive actions by those
that are in unmanageable situations. While previous cost
displays high explanatory power, it is strongly influenced
by factors other than healthcare needs [32,33] and, except
when used as a complement to clinical variables, it does
not enable the identification of target populations.
An imperative for the implementation of health
programmes is that the entire population benefit. Al-
though case-mix systems use multiple clinical data,
other variables such as social variables also influence
people’s health and care outcomes. For this reason, a
system that considers future care needs based on infor-
mation from prior use may be unfair if there are social
groups whose access to health services is less than their
actual need [34]. Consequently, doubts could be raised
about ethical issues surrounding the implementation of
population stratification, based on the possibility of en-
gendering subtle discrimination against patients in a
more severe state of deprivation. In our study, inclusion
of the deprivation index did not produce a significant
difference in the models’ ability, which is in line with
another study carried out in Canada using administra-
tive and survey data to predict the number of doctor
visits [35]. In any case, maintaining the social variables
is justified as a means of ensuring greater equity in pa-
tient selection [36].
This study analysed the predictive ability of models
based primarily on diagnoses and prescriptions in the
total population over 14 years of age in a geographical
region. However, in order to implement management
programmes for specific diseases, it would be appropri-
ate to also know the capability of these models when ap-
plied to subgroups of patients diagnosed with these
diseases. Furthermore, from the implementation of Health
Information Technologies (HIT), new data can be ob-
tained that until now were not accessible [37], such as
data on following clinical practice guidelines, patient
treatment adherence, life habits and risk factors, the in-
corporation of which will allow a better description of
the health of the population and could improve the abil-
ity of predictive models.Conclusion
Our study has shown that case-mix systems developed
in the U.S. can be used in a publicly financed healthcare
system with universal health insurance such as that of
the Basque Country, to predict consumption of health
resources. Also, the additional use of information from
diagnoses and prescriptions mitigates some of the limita-
tions attributable to the information systems in use and
produces better results. The use of these systems allows
the identification of people at risk of requiring high
health resource consumption in the future and whosesituation is potentially preventable through the imple-
mentation of proactive interventions.
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